ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
109.64
-1.30 (-1.17%)
At close: Dec 4, 2025, 4:00 PM EST
108.57
-2.07 (-1.87%)
Pre-market: Dec 5, 2025, 5:16 AM EST
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $8.22 billion as of December 5, 2025. Its market cap has increased by 1,483.45% in one year.
Market Cap
8.22B
Enterprise Value
8.27B
1-Year Change
1,483.45%
Ranking
Category
Stock Price
$109.64
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $8.22B, an increase of 3,546.94%. That is a compound annual growth rate of 41.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 8.22B | 1,755.02% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | 582.13M | 95.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.07B |
| Johnson & Johnson | 495.91B |
| AbbVie | 407.28B |
| UnitedHealth Group | 308.16B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 254.68B |
| Thermo Fisher Scientific | 218.28B |